Bellicum Pharmaceuticals, Inc.

Bellicum is a clinical stage biopharmaceutical company, focused on discovering and developing novel cellular immunotherapies for the treatment of various forms of cancer.  Bellicum recently completed a success IPO on the Nasdaq market and trades under the ticker symbol BLCM.

View All Investments